Skip to main content
Top
Published in: BMC Neurology 1/2015

Open Access 01-12-2015 | Research article

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis

Authors: Benjamin Berger, Tilman Hottenrott, Jonas Leubner, Rick Dersch, Sebastian Rauer, Oliver Stich, Harald Prüss

Published in: BMC Neurology | Issue 1/2015

Login to get access

Abstract

Background

The analysis of cerebrospinal fluid (CSF) is usually done under steady-state conditions, when proteins (e.g., immunoglobulins) reach diffusion equilibrium between blood and CSF. However, little data has been published on CSF analysis under non-steady-state conditions after therapeutic apheresis. By reducing serum proteins (e.g., immunoglobulins), while leaving CSF unchanged, therapeutic apheresis might cause spuriously altered intrathecal immunoglobulin fractions.

Methods

Based on the incidental finding of plasma exchange-induced increased intrathecal immunoglobulin fractions in a cohort of 12 unsystematically selected patients with various neurological disorders, we retrospectively investigated CSF results that had been raised during routine diagnostic work-up from 41 consecutive neurological patients (predominantly Guillain-Barré syndrome and autoimmune encephalitis) treated with plasmapheresis or immunoadsorption in a tertiary care university hospital in whom lumbar puncture (LP) was performed after a varying number of treatments of therapeutic apheresis.

Results

Only when LP was performed 1 day after therapeutic apheresis, spurious quantitative intrathecal immunoglobulin (Ig) synthesis of at least one subclass (IgG, IgA and/or IgM) was found in 68.4 % of the patients, irrespective of the number of treatments, in all age groups and independent of other previous immunotherapies (e.g., steroids). This phenomenon occurred only transiently and was almost always accompanied by an elevation of the IgG index. In one patient, an elevated IgG index was noticed even 2 days after plasmapheresis. Neither quantitative Ig synthesis, nor elevated IgG index was observed when the LP was performed three or more days after therapeutic apheresis.

Conclusions

Spurious quantitative intrathecal Ig synthesis and increased IgG index are common findings shortly after plasmapheresis or immunoadsorption due to altered serum immunoglobulin levels. Knowledge of this phenomenon is needed for clinicians to prevent false interpretations leading to unnecessary diagnostic and therapeutic procedures. Misdiagnoses can be avoided by considering the characteristic CSF constellation including absence of oligoclonal bands and the close temporal relation to therapeutic apheresis.
Literature
1.
go back to reference Reiber H. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122:189–203.CrossRefPubMed Reiber H. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 1994;122:189–203.CrossRefPubMed
2.
go back to reference Reiber HFK. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta. 1987;163:319–28.CrossRefPubMed Reiber HFK. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta. 1987;163:319–28.CrossRefPubMed
3.
go back to reference Reiber H, Peter J. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101–22.CrossRefPubMed Reiber H, Peter J. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci. 2001;184:101–22.CrossRefPubMed
4.
go back to reference Gwathmey K, Balogun RA, Burns T. Commentary Neurologic Indications for Therapeutic Plasma Exchange: 2013 Update. J Clin Apher. 2014;29:211–9.CrossRefPubMed Gwathmey K, Balogun RA, Burns T. Commentary Neurologic Indications for Therapeutic Plasma Exchange: 2013 Update. J Clin Apher. 2014;29:211–9.CrossRefPubMed
5.
go back to reference Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs B, van Doorn P. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–82.CrossRefPubMed Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs B, van Doorn P. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–82.CrossRefPubMed
6.
go back to reference Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.CrossRefPubMedPubMedCentral Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.CrossRefPubMedPubMedCentral
7.
go back to reference Madžar D, Maihöfner C, Zimmermann R, Schwab S, Kornhuber J, Lewczuk P. Cerebrospinal fluid under non-steady state condition caused by plasmapheresis. J Neural Transm. 2011;118:219–22.CrossRefPubMed Madžar D, Maihöfner C, Zimmermann R, Schwab S, Kornhuber J, Lewczuk P. Cerebrospinal fluid under non-steady state condition caused by plasmapheresis. J Neural Transm. 2011;118:219–22.CrossRefPubMed
8.
go back to reference Reiber H. Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4:99–107.CrossRefPubMed Reiber H. Cerebrospinal fluid--physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult Scler. 1998;4:99–107.CrossRefPubMed
9.
go back to reference Correale J, De los Milagros Bassani Molinas M. Oligoclonal bands and antibody responses in multiple sclerosis. J Neurol. 2002;249:375–89.CrossRefPubMed Correale J, De los Milagros Bassani Molinas M. Oligoclonal bands and antibody responses in multiple sclerosis. J Neurol. 2002;249:375–89.CrossRefPubMed
10.
go back to reference Mühlhausen J, Kitze B, Huppke P, Müller GA, Koziolek MJ. Apheresis in treatment of acute inflammatory demyelinating disorders. Atheroscler Suppl. 2015;18:251–6.CrossRefPubMed Mühlhausen J, Kitze B, Huppke P, Müller GA, Koziolek MJ. Apheresis in treatment of acute inflammatory demyelinating disorders. Atheroscler Suppl. 2015;18:251–6.CrossRefPubMed
Metadata
Title
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
Authors
Benjamin Berger
Tilman Hottenrott
Jonas Leubner
Rick Dersch
Sebastian Rauer
Oliver Stich
Harald Prüss
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2015
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-015-0515-x

Other articles of this Issue 1/2015

BMC Neurology 1/2015 Go to the issue